Passage Bio (PASG) Metrics: History & Chart

Passage Bio, Inc.(PASG)

Biotechnology · Philadelphia, PA

$4.12+0.03 (+0.73%)

Delayed quote: Oct 6, 2026, 12:52 PM EDT

About Passage Bio, Inc.

Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system. Their advanced pipeline includes PBGM01, designed to treat infantile GM1 gangliosidosis by utilizing a proprietary AAVhu68 capsid to deliver a functional GLB1 gene, which codes for the lysosomal acid beta-galactosidase enzyme, to both the brain and peripheral tissues. Another key program, PBFT02, employs an AAV1 capsid to introduce a functional granulin (GRN) gene, encoding progranulin (PGRN), to the brain as a treatment for FTD-GRN. Additionally, PBKR03 is under development for infantile Krabbe disease, leveraging a proprietary AAVhu68 capsid to deliver a functional GALC gene, responsible for producing the hydrolytic enzyme galactosylceramidase, to the brain and surrounding tissues. The company's portfolio also features PBML04 for metachromatic leukodystrophy, PBAL05 for amyotrophic lateral sclerosis, and PBCM06 for Charcot-Marie-Tooth Type 2A. Passage Bio maintains a significant research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program, alongside a development services and clinical supply agreement with Catalent Maryland, Inc. Established in 2017, the company's headquarters are located in Philadelphia, Pennsylvania.

Philadelphia, PA

24 employees

www.passagebio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: William Chou

View full financials

Third-Party DCF Estimate (FMP)	$6.70
Price Gap vs Third-Party Estimate	+56.17%

7D Total Return	-12.61%
30D Total Return	-12.04%
YTD Total Return	-65.34%
1Y Total Return	-48.55%
3Y Total Return	-67.80%
5Y Total Return	-97.76%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-65.34%
2025	+4.06%
2024	-43.86%
2023	-26.81%
2022	-78.27%
2021	-75.17%
2020

CAGR TTM	-48.39%
CAGR 3Y	-31.45%
CAGR 5Y	-53.23%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

PASG Valuation Metrics

PASG Stock Price Metrics

PASG Dividend Metrics

PASG Growth Rate Metrics

PASG Discounted Cash Flow Metrics

PASG Returns By Period

PASG Yearly Returns

PASG Average Annual Returns By Period (CAGR)

PASG Revenue Metrics

PASG PE Ratio Metrics

PASG PS Ratio Metrics

PASG PB Ratio Metrics

PASG Price to Free Cash Flow Ratio Metrics

PASG Debt to Equity Ratio Metrics

PASG PEG Ratio Metrics

PASG FCF Yield

PASG Earnings Yield

PASG EBITDA Yield

PASG OCF Yield

PASG EV/EBIT Ratio Metrics

PASG EV/EBITDA Ratio Metrics

PASG EV/Assets Ratio Metrics

PASG EV/Sales Ratio Metrics

PASG Current Ratio Metrics

PASG Quick Ratio Metrics

PASG ROIC Metrics

PASG Return on Assets Metrics

PASG Return on Equity Metrics

PASG Net Profit Margin Metrics

PASG Gross Profit Margin Metrics

PASG Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	2.95
PB Ratio Avg TTM	1.15
PB Ratio Avg 3Y	0.66
Current VS TTM Avg	+155.94%
Current VS 3Y Avg	+344.62%
Current VS 5Y Avg	+454.11%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.64
Debt/Equity Ratio Avg 3Y	0.37
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.24
Ev/Assets Ratio Avg TTM	0.08
Ev/Assets Ratio Avg 3Y	0.25
Current VS TTM Avg	+207.02%
Current VS 3Y Avg	-3.71%
Current VS 5Y Avg	+1.52%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	1.22
Current Ratio Avg TTM	2.11
Current Ratio Avg 3Y	4.72
Current VS TTM Avg	-42.49%
Current VS 3Y Avg	-74.28%
Current VS 5Y Avg	-83.30%

Quick Ratio	1.22
Quick Ratio Avg TTM	2.11
Quick Ratio Avg 3Y	4.72
Current VS TTM Avg	-42.49%
Current VS 3Y Avg	-74.28%
Current VS 5Y Avg	-83.30%

ROIC	(889.92%)
ROIC Avg 3Y	(87.37%)
ROIC Avg 5Y	(75.00%)
Current VS 3Y Avg	-918.63%
Current VS 5Y Avg	-1086.51%
Current VS 10Y Avg	-1357.55%

ROA	(143.44%)
ROA Avg TTM	(18.99%)
ROA Avg 3Y	(14.64%)
Current VS TTM Avg	-655.40%
Current VS 3Y Avg	-880.07%
Current VS 5Y Avg	-938.61%

ROE	(810.41%)
ROE Avg TTM	(333.56%)
ROE Avg 3Y	(105.05%)
Current VS TTM Avg	-142.96%
Current VS 3Y Avg	-671.47%
Current VS 5Y Avg	-841.79%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A